International Patent: ANTIBODY-DRUG CONJUGATE TARGETING DLL3 AND USE THEREOF

GENEVA, Oct. 30 -- HELIXON BIOTECHNOLOGY (SUZHOU) CO., LTD filed a patent application (CN2026/092680) for “ANTIBODY-DRUG CONJUGATE TARGETING DLL3 AND USE THEREOF”. With publication no. WO/2026/223773, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: C07K 16/28

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....